Jing Wei
Impact in
- Pharmacology top 0.5%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications
Papers in
- Surgery 28
- Tissue Engineering and Regenerative Medicine 18
- Co-authors
- Weijia Kong (3 shared papers)Zizheng Wang (2 shared papers)Zhuorong Li (2 shared papers)Shuyi Si (2 shared papers)Jian‐Dong Jiang (1 shared paper)Parveen Abidi (1 shared paper)Yue Wang (1 shared paper)Yanling Wang (1 shared paper)
- Journals
- Stem Cell Research & Therapy (4 papers)Chemical Engineering Journal (4 papers)Journal of Biomedical Materials Research Part A (3 papers)Journal of Materials Chemistry B (2 papers)Clinical Rheumatology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jing Wei
135 papers receiving 4.5k citations
Jing Wei's Hit Papers
Peers
Comparison fields: 5 of 136
- Pharmacology 1.2k
- Pharmacology 492
- Biomaterials 439
- Genetics 314
- Rehabilitation 129
Countries citing papers authored by Jing Wei
This map shows the geographic impact of Jing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Wei more than expected).
Fields of papers citing papers by Jing Wei
This network shows the impact of papers produced by Jing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Wei. The network helps show where Jing Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Hit paper breakdown → | 2004 | 1188 |
| 2 | 2009 | 368 | |
| 3 | Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells Hit paper breakdown → | 2020 | 214 |
| 4 | 2008 | 210 | |
| 5 | 2019 | 103 | |
| 6 | 2019 | 95 | |
| 7 | Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response. | 2005 | 85 |
| 8 | 2019 | 79 | |
| 9 | 2018 | 75 | |
| 10 | 2015 | 68 | |
| 11 | 2014 | 62 | |
| 12 | 2018 | 60 | |
| 13 | 2022 | 56 | |
| 14 | 2021 | 54 | |
| 15 | 2015 | 54 | |
| 16 | 2015 | 51 | |
| 17 | 2017 | 49 | |
| 18 | 2019 | 49 | |
| 19 | 2022 | 48 | |
| 20 | 2016 | 48 |
About Jing Wei
Jing Wei is a scholar working on Surgery, Molecular Biology, Biomedical Engineering, Immunology and Biomaterials, having authored 143 papers that have together received 4.6k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (18 papers), Tissue Engineering and Regenerative Medicine (18 papers), Electrospun Nanofibers in Biomedical Applications (17 papers), Mesenchymal stem cell research (12 papers), Immune Cell Function and Interaction (9 papers), Graphene and Nanomaterials Applications (9 papers), Wound Healing and Treatments (6 papers) and Berberine and alkaloids research (6 papers). The work is most often cited by research in Pharmacology (1.2k citations), Pharmacology (492 citations), Biomaterials (439 citations), Genetics (314 citations) and Rehabilitation (129 citations). Jing Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Weijia Kong, Zizheng Wang, Zhuorong Li, Shuyi Si, Jian‐Dong Jiang, Parveen Abidi, Yue Wang, Yanling Wang, Jingwen Liu and Satoru Inaba. Their work appears in journals such as Stem Cell Research & Therapy, Chemical Engineering Journal, Journal of Biomedical Materials Research Part A, Journal of Materials Chemistry B and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.